Precision BioSG
AI-Driven Target Identification Cuts Discovery Time in Half
50%
Faster Drug Discovery
3x
More Candidates Identified
60%
Less Time on Data Prep
The Challenge
The R&D team was spending 60% of their time on data preparation and literature review, leaving limited bandwidth for actual scientific analysis.
Solution & Outcome
Bio R&D unified all experimental and clinical datasets, and deployed AI target identification that surfaced 3 viable drug candidates in 4 months — a process that previously took 2 years.
Related Cases
Sino Pharma Group
Top-50 China Pharma
10x Faster Cross-Border Regulatory Submissions
KyoPharma CMO
Contract Manufacturer
GMP Batch Failure Rate Slashed by 35%
MedCo ASEAN
Regional Pharma Co.
Market Access Strategy Powered by AI Insights
Start Your Digital Transformation
Discover how HealthTech Nexus can help your organization achieve breakthroughs